ClinicalTrials.Veeva

Menu

Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

A

Ain Shams University

Status

Completed

Conditions

Mitral Valve Disease
Atrial Fibrillation
Deep Vein Thrombosis

Treatments

Other: Anticoagulation Stewardship Program

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims at evaluating the implementation of clinical-pharmacist-led anticoagulation stewardship program in Egyptian tertiary hospital to promote a culture of safety around anticoagulants.

Full description

One of the high-alert medication categories that may cause significant patient harm if not used correctly is anticoagulants. It is not clear if medication errors are more common with this category in specific compared to other medication categories, but the ramifications of a medication error with the use of anticoagulation agents is without a doubt detrimental to the patient's health and more serious than most of other drug categories.

This prospective study evaluates the impact of implementing an anticoagulation stewardship program, led by clinical pharmacists, on anticoagulation therapy outcomes during patient hospitalization by the percent of medication errors reduction, percent of adverse drug events reduction, and percent of evidence-based guidelines compliance improvement.

Enrollment

233 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All hospitalized patients on therapeutic anticoagulant medication during their hospitalization period.

Exclusion criteria

  1. Patients whose age is less than 18 years old.
  2. Patients who were admitted for less than 24 hours for patient on parenteral anticoagulants and less than 48 hours for patient on warfarin.
  3. Patients already admitted for bleeding or thrombosis.
  4. Malignancy patients.

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

233 participants in 2 patient groups

Pre program implementation
No Intervention group
Description:
All hospitalized patients on therapeutic anticoagulant medication during the pre-implementation period of the anticoagulation stewardship program.
Post program implementation
Experimental group
Description:
All hospitalized patients on therapeutic anticoagulant medication during the post-implementation period of the anticoagulation stewardship program.
Treatment:
Other: Anticoagulation Stewardship Program

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems